greeksoup/ stock research

Acadia Healthcare (ACHC) FY2024 results: revenue $3.2 billion, up 7.7% on the year

Acadia Healthcare Company, Inc. (ACHC) reported revenue of $3.2 billion for fiscal 2024, the year ended 31 December 2024, up 7.7% on the year before. Net income was $256 million, and diluted earnings per share $2.78. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.

Revenue
$3.2 billion
+7.7% on the year
FY2017FY2024
Operating margin
10.8%
-0.9% a year earlier
FY2017FY2024
Net income
$256 million
FY2017FY2024
Diluted EPS
$2.78
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue3,1542,9292,610+7.7%
Operating income342-25.4374
Operating margin10.8%-0.9%14.3%
Pre-tax income342-25.4374
Income tax77.4-9.794.1
Effective tax rate22.6%n/a25.2%
Net income256-21.7273
Net margin8.1%-0.7%10.5%
Diluted EPS$2.78-$0.24$2.98
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow130462381-71.9%
Capital expenditure690424296+62.8%
Free cash flow-56138.284.4
Free cash flow margin-17.8%1.3%3.2%
Cash from investing-736-397-306
Cash from financing583-62.7-111
Depreciation and amortisation150132118+13.0%
Share-based compensation37.132.329.6+14.9%
Diluted shares, weighted92m91m92m+1.2%
Shares outstanding at period end92m91m90m+0.6%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity3,0742,7822,813+10.5%
Redeemable equity11710688.3+10.8%
Debt1,9571,3721,386+42.7%
Operating lease liabilities102101116+1.0%
Finance lease liabilities10.810.910.9-0.8%
Other liabilities697988574-29.5%
Total liabilities and equity5,9575,3594,988+11.2%
Fixed assets2,8532,2671,952+25.9%
Goodwill2,2652,2262,223+1.7%
Intangible assets70.073.376.0-4.5%
Cash and equivalents76.310097.6-23.8%
Receivables365361322+1.1%
Inventory5.75.35.1+6.7%
Other assets322326312-1.4%
Total assets5,9575,3594,988+11.2%

10-K for the year ended 31 December 2024, filed 27 February 2025: the filing.